한국어
English
Archive
Year
Class/Forum
Presentation Title
Speaker
GBC 2017
Keynote & Plenary
Keynote Speech
Reform of regulations for healthcare convergence in 4th industrial revolution
Min-Hwa Lee
Chairman / Professor,
KCERN / KAIST
GBC 2017
Keynote & Plenary
Keynote Speech
From Treatment to Cure: Striving for the Ultimate Goal in Healthcare Innovation
Michael Goettler
Global President,
Rare Disease for Pfizer's Innovative Health Business
GBC 2017
Keynote & Plenary
Keynote Speech
Small and Strong - Winning models in Korea R&D
Axel Baur
Senior Partner, Leader of McKinsey’s Asia Healthcare Practice,
Mckinsey
GBC 2017
Keynote & Plenary
Keynote Speech
Healthcare in the age of Cognitive Computing
Michael S. Weiner
Chief Medical Information Officer,
IBM Healthcare
GBC 2017
Keynote & Plenary
Plenary Session
Prediction of Inherited Susceptibility for major Cancers by Machine-Learning Method
Sung-Hou Kim
Professor,
UC Berkeley
GBC 2017
Keynote & Plenary
Plenary Session
Modeling of human genetic diseases using induced pluripotent stem cells
Yong-Mahn Han
Professor,
KAIST
GBC 2017
Keynote & Plenary
Plenary Session
Applications of 3D printing in Biomedical Engineering
Won-Soo Yun
Professor / CEO,
Korea Polytechnic University / T&R Biofab Co., ltd.
GBC 2017
Vaccine
Vaccine Forum
Innovation and Challenges in Vaccine development
Stephen Lockhart
Vice President,
Pfizer
GBC 2017
Vaccine
Vaccine Forum
The history, now and future of Vaccine development
Rino Rappuoli
Chief Scientist and Head External R&D,
GSK
GBC 2017
Vaccine
Vaccine Forum
Current status and future of regulatory science of Biologics
Ian Feavers
Head of Bacteriology,
NIBSC
GBC 2017
Vaccine
Vaccine Forum
Development of Zika vaccines
Inkyu Yoon
Deputy Director General of Science,
IVI
GBC 2017
Vaccine
Vaccine Forum
The use of novel adjuvants to enhance and broaden the immune response elicited by human vaccines
Ralf Wagner
Head of Section Viral Vaccines,
PEI
GBC 2017
Vaccine
Vaccine Forum
Regulatory Challenges in the Design, Analysis and Interpretation of Immumobridging Vaccine Trials using Correlates of Protection
Catherlin Njue
,
Health Canada
GBC 2017
Vaccine
Vaccine Forum
Development of an Ebola Vaccine in the Midst of an Unprecedented Epidemic
Jayanthi Wolf
Director,
MSD
GBC 2017
Recombinant Protein Products
Recombinant Protein Products Forum
History, Current Status and Future of Recombinant Protein Products
Elwyn Griffiths
Formerly Director General,
Former Health Canada
